APA (7th ed.) Citation

Donkers, J., Zehnder, B., Van Westen, G. J. P., Kwakkenbos, M. J., IJzerman, A. P., Oude Elferink, R. P. J., . . . Van de Graaf, S. F. J. (2017). Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP. Scientific reports, 7, . https://doi.org/10.1038/s41598-017-15338-0

Chicago Style (17th ed.) Citation

Donkers, Joanne, Benno Zehnder, Gerard J. P. Van Westen, Mark J. Kwakkenbos, Adriaan P. IJzerman, Ronald P. J. Oude Elferink, Ulrich Beuers, Stephan Urban, and Stan F. J. Van de Graaf. "Reduced Hepatitis B and D Viral Entry Using Clinically Applied Drugs as Novel Inhibitors of the Bile Acid Transporter NTCP." Scientific Reports 7 (2017). https://doi.org/10.1038/s41598-017-15338-0.

MLA (9th ed.) Citation

Donkers, Joanne, et al. "Reduced Hepatitis B and D Viral Entry Using Clinically Applied Drugs as Novel Inhibitors of the Bile Acid Transporter NTCP." Scientific Reports, vol. 7, 2017, https://doi.org/10.1038/s41598-017-15338-0.